Skip to main content
Equibles
BCRX logo

BCRX · Biocryst Pharmaceuticals Inc · Held by Funds

Track BCRX — free

Use BCRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BCRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.61 -0.07 (-0.91%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$1.96B
Shares
257.30M
Volume · Nov 13 2.32M Avg daily vol (3M) 4.87M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of BCRX by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 20.49% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 3.16% 8,127,064
Index ETFs 17.33% 44,583,589
Active ETFs 0.81% 2,093,484
Active funds 7.96% 20,476,463
Unclassified 0.08% 211,338
All registered funds 29.34% 75,491,938
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding BCRX

227 fund positions
Fund Balance Value % of Fund Open
State Street(R) SPDR(R) S&P(R) Biotech ETF 9,581,829 $95,818,290 0.89%
VANGUARD TOTAL STOCK MARKET INDEX FUND 8,067,362 $80,673,620 0.00%
iShares Russell 2000 ETF 6,047,716 $60,477,160 0.07%
VANGUARD SMALL-CAP INDEX FUND 2,911,465 $29,114,650 0.02%
VANGUARD EXTENDED MARKET INDEX FUND 2,838,097 $28,380,970 0.03%
abrdn Healthcare Investors 2,323,964 $23,239,640 1.71%
Fidelity Small Cap Index Fund 2,538,144 $22,792,533 0.07%
VANGUARD STRATEGIC EQUITY FUND 2,255,073 $22,550,730 0.19%
iShares Russell 2000 Growth ETF 2,149,216 $21,492,160 0.14%
abrdn Healthcare Opportunities Fund 2,088,571 $20,885,710 2.53%
VANGUARD SMALL-CAP GROWTH INDEX FUND 1,671,689 $16,716,890 0.04%
iShares Biotechnology ETF 1,528,937 $15,289,370 0.17%
College Retirement Equities Fund - Total Global Stock Account 1,386,232 $13,862,320 0.01%
VANGUARD RUSSELL 2000 INDEX FUND 1,334,049 $12,940,275 0.07%
VANGUARD EXPLORER FUND 1,341,254 $12,044,461 0.05%
Fidelity Extended Market Index Fund 1,214,259 $11,778,312 0.03%
Schwab U.S. Small-Cap ETF 1,174,592 $11,393,542 0.05%
Nuveen Quant Small Cap Equity Fund 1,123,960 $10,093,161 0.25%
Janus Henderson Small/Mid Cap Growth Alpha ETF 1,078,429 $9,684,292 0.92%
abrdn Life Sciences Investors 898,336 $8,983,360 1.30%
BlackRock Advantage Small Cap Core Fund 853,039 $8,274,478 0.15%
U.S. MICRO CAP PORTFOLIO 831,862 $7,470,121 0.10%
Invesco Biotechnology & Genome ETF 826,963 $7,426,128 2.63%
Fidelity Enhanced Small Cap Core ETF 693,212 $6,932,120 0.12%
Dimensional U.S. Small Cap ETF 770,732 $6,921,173 0.05%
iShares U.S. Small-Cap Equity Factor ETF 753,414 $6,765,658 0.17%
AMG GW&K Small Cap Core Fund 674,485 $6,744,850 0.87%
Nuveen Quant Small/Mid Cap Equity Fund 735,750 $6,607,035 0.25%
VANGUARD HEALTH CARE INDEX FUND 631,962 $6,130,031 0.03%
VANGUARD STRATEGIC SMALL-CAP EQUITY FUND 556,983 $5,569,830 0.18%
Schwab Small-Cap Index Fund 565,590 $5,078,998 0.07%
Fidelity Total Market Index Fund 480,444 $4,660,307 0.00%
First Trust Small Cap Growth AlphaDEX Fund 516,595 $4,639,023 0.36%
Principal U.S. Small-Cap ETF 445,890 $4,458,900 0.19%
Master Small Cap Index Series 423,366 $4,233,660 0.07%
Fidelity Series Total Market Index Fund 382,225 $3,707,583 0.00%
iShares Core S&P Total U.S. Stock Market ETF 333,829 $3,338,290 0.00%
ALPS Medical Breakthroughs ETF 313,539 $3,041,328 1.27%
AMG GW&K Small Cap Growth Fund 326,414 $2,931,198 1.43%
Direxion Daily S&P Biotech Bull 3X Shares 324,702 $2,915,824 0.59%
Nuveen Small Cap Blend Index Fund 308,617 $2,771,381 0.07%
Strategic Advisers U.S. Total Stock Fund 284,065 $2,755,431 0.00%
Virtus NFJ Small-Cap Value Fund 256,833 $2,568,330 0.99%
EQ/2000 Managed Volatility Portfolio 252,032 $2,520,320 0.07%
Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF 259,049 $2,512,775 0.23%
VANGUARD RUSSELL 2000 GROWTH INDEX FUND 254,208 $2,465,818 0.14%
SMALL COMPANY GROWTH PORTFOLIO 238,756 $2,387,560 0.14%
Janus Henderson Small Cap Growth Alpha ETF 248,560 $2,232,069 0.62%
Fidelity Small Cap Growth Index Fund 218,173 $2,181,730 0.14%
HUSSMAN STRATEGIC MARKET CYCLE FUND 200,000 $2,000,000 0.57%
Showing 1–50 of 227 positions
Key facts CIK 882796 CUSIP 09058V103 13F (30d) 246 filings 226 filers Visit website Investor relations